Neulasta

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2002-2016
0520022016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
The search for treatments to counter potentially lethal radiation-induced injury over the past several decades has led to the… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2015
2015
Astronauts could be exposed to solar particle event (SPE) radiation, which is comprised mostly of proton radiation. Proton… (More)
Is this relevant?
2015
2015
Despite significant scientific advances toward the development of a safe, nontoxic and effective radiation countermeasure for… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
2014
2014
In an effort to expand the worldwide pool of available medical countermeasures (MCM) against radiation, the PEGylated G-CSF (PEG… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
Introduction: Little is known about the effects stem cell mobilizers (GCSF) such as neulasta (pegfilgrastim) or neupogen… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2008
Review
2008
Neulasta (pegfilgrastim) is a PEGylated version of its parent molecule NEUPOGEN (Filgrastim). This work describes the formulation… (More)
Is this relevant?
2007
2007
The myelotoxicity of most chemotherapeutic regimens used to treat children and adolescents with cancer require the use of daily… (More)
Is this relevant?
Review
2003
Review
2003
Filgrastim (r-metHuG-CSF) was approved in the United States in 1991 for use in decreasing the incidence of infection, as… (More)
Is this relevant?